Company Filing History:
Years Active: 2018-2020
Title: The Innovative Contributions of Karin Neimann
Introduction
Karin Neimann is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of photodynamic therapy through her innovative research and patents. With a total of 2 patents, her work focuses on the development of conjugates that enhance the effectiveness of treatments for various vascular diseases and tumors.
Latest Patents
Karin Neimann's latest patents include groundbreaking work on conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers. These conjugates are designed for use in photodynamic therapy (PDT), particularly vascular-targeted PDT (VTP). They are aimed at treating tumors and nonneoplastic vascular diseases, such as age-related macular degeneration. Additionally, her patents cover the use of these conjugates for tumor diagnosis through various techniques.
Career Highlights
Karin Neimann is associated with Yeda Research and Development Co. Ltd., where she continues to push the boundaries of medical research. Her innovative approach has garnered attention in the scientific community, contributing to advancements in therapeutic techniques.
Collaborations
Throughout her career, Karin has collaborated with notable colleagues, including Avigdor Scherz and Yoram Salomon. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Karin Neimann's contributions to the field of photodynamic therapy exemplify the power of innovation in medicine. Her work not only advances treatment options but also enhances diagnostic techniques, showcasing the importance of research in improving patient outcomes.